Glycomic characterization of basal tears and changes with diabetes and diabetic retinopathy

Glycobiology

Volumn 25, Issue 3, 2013, Pages 269-283

  Nguyen Khuong, Terry ^a   Everest Dass, Arun V ^a   Kautto, Liisa ^a   Zhao, Zhenjun ^b   Willcox, Mark D P ^b   Packer, Nicolle H ^a  

^a MACQUARIE UNIVERSITY   (Australia)

^b UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

basal tears; diabetes; diabetic retinopathy; glycomics; tear film

Indexed keywords

N ACETYLGLUCOSAMINE; N LINKED TEAR PROTEIN; O LINKED TEAR PROTEIN; TEAR PROTEIN; UNCLASSIFIED DRUG; POLYSACCHARIDE;

ARTICLE; CLINICAL ARTICLE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIABETIC RETINOPATHY; FEMALE; GLYCOBIOLOGY; HUMAN; LACRIMAL FLUID; LIQUID CHROMATOGRAPH; LIQUID CHROMATOGRAPHY; MALE; MASS SPECTROMETER; MASS SPECTROMETRY; MULTICENTER STUDY; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN STRUCTURE; SIALYLATION; TEAR FILM; CASE CONTROL STUDY; CHEMISTRY; METABOLISM;

CASE-CONTROL STUDIES; DIABETIC RETINOPATHY; HUMANS; POLYSACCHARIDES; TEARS;

EID: 84939815482     PISSN: 09596658     EISSN: 14602423     Source Type: Journal    
DOI: 10.1093/glycob/cwu108     Document Type: Article

References (39)

1. Beck A, Wagner-Rousset E, Bussat MC, Lokteff M, Klinguer-Hamour C, Haeuw JF, Goetsch L, Wurch T, Van Dorsselaer A, Corvaia N. 2008. Trends in glycosylation, glycoanalysis and glycoengineering of therapeutic antibodies and Fc-fusion proteins. Curr Pharm Biotechnol. 9:482-501.
2. de Godoy LM, Olsen JV, de Souza GA, Li G, Mortensen P, Mann M. 2006. Status of complete proteome analysis by mass spectrometry: SILAC labeled yeast as a model system. Genome Biol. 7:R50.
3. de Souza GA, Godoy LM, Mann M. 2006. Identification of 491 proteins in the tear fluid proteome reveals a large number of proteases and protease inhibitors. Genome Biol. 7:R72.
4. Ding J, Wong TY. 2012. Current epidemiology of diabetic retinopathy and diabetic macular edema. Curr Diab Rep. 12:346-354.
5. Domon B, Costello CE. 1988. A systematic nomenclature for carbohydrate fragmentations in FAB-MS/MS spectra of glycoconjugates. Glycoconj J. 5:397-409.
6. Ellingham RB, Berry M, Stevenson D, Corfield AP. 1999. Secreted human conjunctival mucus contains MUC5AC glycoforms. Glycobiology. 9: 1181-1189.
7. Everest-Dass AV, Abrahams JL, Kolarich D, Packer NH, Campbell MP. 2013. Structural feature ions for distinguishing N- and O-linked glycan isomers by LC-ESI-IT MS/MS. J Am Soc Mass Spectrom. 24:895-906.
8. Everest-Dass AV, Jin D, Thaysen-Andersen M, Nevalainen H, Kolarich D, Packer NH. 2012. Comparative structural analysis of the glycosylation of salivary and buccal cell proteins: Innate protection against infection by Candida albicans. Glycobiology. 22:1465-1479.
9. Foulks GN, Bron AJ. 2003. Meibomian gland dysfunction: A clinical scheme for description, diagnosis, classification, and grading. Ocul Surf. 1:107-126.
10. Fullard RJ, Snyder C. 1990. Protein levels in nonstimulated and stimulated tears of normal human subjects. Invest Ophthalmol Vis Sci. 31:1119-1126.
11. Fullard RJ, Tucker DL. 1991. Changes in human tear protein levels with progressively increasing stimulus. Investig Ophthalmol Vis Sci. 32:2290-2301.
12. Goebbels M. 2000. Tear secretion and tear film function in insulin dependent diabetics. Br J Ophthalmol. 84:19-21.
13. Grus FH, Podust VN, Bruns K, Lackner K, Fu S, Dalmasso EA, Wirthlin A, Pfeiffer N. 2005. SELDI-TOF-MS ProteinChip array profiling of tears from patients with dry eye. Invest Ophthalmol Vis Sci. 46:863-876.
14. Grus FH, Sabuncuo P, Dick HB, Augustin AJ, Pfeiffer N. 2002. Changes in the tear proteins of diabetic patients. BMC Ophthalmol. 2:4.
15. Guzman-Aranguez A, Argueso P. 2010. Structure and biological roles of mucintype O-glycans at the ocular surface. Ocul Surf. 8:8-17.
16. Guzman-Aranguez A, Mantelli F, Argueso P. 2009. Mucin-type O-glycans in tears of normal subjects and patients with non-Sjogren's dry eye. Invest Ophthalmol Vis Sci. 50:4581-4587.
17. Harvey DJ, Royle L, Radcliffe CM, Rudd PM, Dwek RA. 2008. Structural and quantitative analysis of N-linked glycans by matrix-assisted laser desorption ionization and negative ion nanospray mass spectrometry. Anal Biochem. 376:44-60.
18. Herber S, Grus FH, Sabuncuo P, Augustin AJ. 2001. Two-dimensional analysis of tear protein patterns of diabetic patients. Electrophoresis. 22:1838-1844.
19. Jensen PH, Karlsson NG, Kolarich D, Packer NH. 2012. Structural analysis of N- and O-glycans released from glycoproteins. Nat Protoc. 7:1299-1310.
20. Kawai S, Nakajima T, Hokari S, Komoda T, Kawai K. 2002. Apolipoprotein A-I concentration in tears in diabetic retinopathy. Ann Clin Biochem. 39:56-61.
21. Kolarich D, Jensen PH, Altmann F, Packer NH. 2012. Determination of sitespecific glycan heterogeneity on glycoproteins. Nat Protoc. 7:1285-1298.
22. Koss MJ, Naser H, Sener A, Ackermann H, Al-Sarireh F, Singh P, Koch FH. 2012. Combination therapy in diabetic macular oedema and retinal vein occlusion - past and present. Acta Ophthalmol. 90:580-589.
23. Lemp MA. 1995. Report of the National Eye Institute/Industry Workshop on Clinical Trials in Dry Eyes. CLAO J. 21:221-232.
24. Moschos MM, Rouvas AA, Papadimitriou S, Kotsolis A, Sitaras N, Apostolopoulos M. 2008. Quantitative determination of glycosaminoglycans in tears of diabetic patients. Clin Ophthalmol. 2:581-584.
25. Nakano T, Sugawara M, Kawakami H. 2001. Sialic acid in human milk: Composition and functions. Acta Paediatr Taiwan. 42:11-17.
26. Ozcan S, An HJ, Vieira AC, Park GW, Kim JH, Mannis MJ, Lebrilla CB. 2013. Characterization of novel O-glycans isolated from tear and saliva of ocular rosacea patients. J proteome Res. 12:1090-1100.
27. Royle L, Roos A, Harvey DJ, Wormald MR, van Gijlswijk-Janssen D, Redwan el RM, Wilson IA, Daha MR, Dwek RA, Rudd PM. 2003. Secretory IgA N- and O-glycans provide a link between the innate and adaptive immune systems. J Biol Chem. 278:20140-20153.
28. Sack RA, Sathe S, Beaton A. 2003. Tear turnover and immune and inflammatory processes in the open-eye and closed-eye environments: Relationship to extended wear contact lens use. Eye Contact Lens. 29:S80-S82; discussion S83-84. S192-194.
29. Schulz BL, Oxley D, Packer NH, Karlsson NG. 2002. Identification of two highly sialylated human tear-fluid DMBT1 isoforms: The major highmolecular- mass glycoproteins in human tears. Biochem J. 366:511-520.
30. Thomsson KA, Karlsson NG, Hansson GC. 1999. Liquid chromatographyelectrospray mass spectrometry as a tool for the analysis of sulfated oligosaccharides from mucin glycoproteins. J Chromatogr A. 854:131-139.
31. Torok Z, Peto T, Csosz E, Tukacs E, Molnar A, Maros-Szabo Z, Berta A, Tozser J, Hajdu A, Nagy V, et al. 2013. Tear fluid proteomics multimarkers for diabetic retinopathy screening. BMC ophthalmol. 13:40.
32. Vieira AC, An HJ, Ozcan S, Kim JH, Lebrilla CB, Mannis MJ. 2012. Glycomic analysis of tear and saliva in ocular rosacea patients: The search for a biomarker. Ocul Surf. 10:184-192.
33. Wessel D, Flugge UI. 1984. A method for the quantitative recovery of protein in dilute solution in the presence of detergents and lipids. Anal Biochem. 138:141-143.
34. Wild S, Roglic G, Green A, Sicree R, King H. 2004. Global prevalence of diabetes: Estimates for the year 2000 and projections for 2030. Diabetes Care. 27:1047-1053.
35. Wilson NL, Schulz BL, Karlsson NG, Packer NH. 2002. Sequential analysis of N- and O-linked glycosylation of 2D-PAGE separated glycoproteins. J Proteome Res. 1:521-529.
36. You J, Fitzgerald A, Cozzi PJ, Zhao Z, Graham P, Russell PJ, Walsh BJ, Willcox M, Zhong L, Wasinger V, et al. 2010. Post-translation modification of proteins in tears. Electrophoresis. 31:1853-1861.
37. Yu L, Chen X, Qin G, Xie H, Lv P. 2008. Tear film function in type 2 diabetic patients with retinopathy. Ophthalmologica. 222:284-291.
38. Yu T, Guo C, Wang J, Hao P, Sui S, Chen X, Zhang R, Wang P, Yu G, Zhang L, et al. 2011. Comprehensive characterization of the site-specific N-glycosylation of wild-type and recombinant human lactoferrin expressed in the milk of transgenic cloned cattle. Glycobiology. 21:206-224.
39. Zhao Z, Liu J, Shi B, He S, Yao X, Willcox MD. 2010. Advanced glycation end product (AGE) modified proteins in tears of diabetic patients. Mol Vis. 16:1576-1584.